Burning Rock, a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, announced that its OverC™...
Guardant Health, Inc., a leading precision oncology company, announced positive results from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode),...
Diadem SpA, a company developing the first blood-based test for the early prediction of progression to Alzheimer's disease (AD), presented clinical data at the...
OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced the completion of a $35 million Series C funding...
Researchers at the Nagourney Cancer Institute and Metabolomycs, Inc. announced in issue of PLOS ONE-a study that showed that COVID-19 related illness severity and...
